IP Library Granted Patent US 11,027,073
Granted Patent B2
US 11,027,073 · App. 16/218,026 · Granted Jun 8, 2021

Therapy assist information and/or tracking device and related methods and systems

Inventors: John Sjolund (Los Altos, CA); Ambika Srinath (San Francisco, CA); Andrew Bochenko (Redwood City, CA); George Crothall (Oceanside, CA); Bryan Mazlish (Palo Alto, CA); Lane Desborough (Thousand Oaks, CA); Jennifer Martin Block (Menlo Park, CA); Sarah Matarese (Milpitas, CA); Linda Mackowiak (Cazenovia, NY)
Assignee: Bigfoot Biomedical, Inc.
A61M5/31546A61B5/0004A61B5/14532A61B5/4836A61B5/4839A61B5/7405A61B5/746A61B5/7435A61B5/7455A61K38/28A61M5/003A61M5/168A61M5/20A61M5/31525A61M5/3202G16H20/13G16H20/17G16H20/60G16H40/63G16H40/67G16H50/20G16H50/30A61B5/14546A61B5/681A61M5/24A61M2005/14208A61M2005/2006A61M2005/3125A61M2205/18A61M2205/3306A61M2205/3561A61M2205/3584A61M2205/502A61M2205/505A61M2205/581A61M2205/582A61M2205/583A61M2209/06A61M2230/201
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,027,073
App. No.
16/218,026
Granted
Jun 8, 2021
Kind
B2
Abstract

A monitoring feature, such as, for example, a pen cap, for an insulin delivery device may include at least one circuit adapted to detect at least one of a capping or decapping of the pen cap from an insulin pen and a processor for using information to the at least one of a capping or decapping of the pen cap. A monitoring feature for an insulin delivery device includes at least one circuit adapted to detect use of the insulin delivery device.

Claims (24)

1. A pen cap for an insulin pen comprising:

at least one input device adapted to receive glucose data;

at least one circuit adapted to detect at least one of a capping or decapping of the pen cap from an insulin pen;

at least one user interface to communicate at least one of therapy relevant information, therapy recommendations, or a time of the at least one of a capping or decapping of the pen cap;

memory to store at least one user-specific dosage parameter or recommended dose; and

at least one processor adapted to determine content presented by the user interface, the processor using information relating to the at least one of a capping or decapping of the pen cap,

wherein the pen cap is adapted to be responsive to the pen cap being capped on the insulin pen for at least a threshold period of time, and to display a recommended correction dose of insulin based on an insulin sensitivity factor and a target glucose value stored in memory.

2. The pen cap of claim 1 , wherein the pen cap is configured to be utilized with one of a long-acting insulin pen or a rapid-acting insulin pen.

3. The pen cap of claim 1 , wherein the pen cap is configure to generate, with the at least one input device, at least a first wireless signal and a second wireless signal, wherein the second wireless signal has a range that is greater than range of the first wireless signal.

4. The pen cap of claim 3 , wherein the first wireless signal is configured to communicate with a glucose monitor when the pen cap is positioned in proximity to the glucose monitor.

5. The pen cap of claim 4 , wherein the second wireless signal is configured to communicate with at least one of the glucose monitor or another remote device.

6. The pen cap of claim 4 , wherein the second wireless signal is configured to automatically communicate with at least one of the glucose monitor or another remote device.

7. The pen cap of claim 4 , wherein the at least one input device comprises at least one wireless radio.

8. The pen cap of claim 1 , wherein the at least one input device comprises a wireless communication interface is configured to communicate with a glucose sensor system via a near field communication protocol when the pen cap is positioned in proximity to at least one part of the glucose sensor system.

9. The pen cap of claim 8 , wherein the wireless communication interface is adapted to communicate with the glucose sensor system using a first wireless communication technique having a first communication range and the wireless communication interface is adapted to communicate with a mobile computing device using a second wireless communication technique having a second communication range, the second communication range being greater than the first communication range.

10. The pen cap of claim 1 , wherein the pen cap is configured to communicate with a glucose sensor system comprising a flash glucose monitor.

11. The pen cap of claim 1 , wherein the content includes a representation of a percentage of active insulin remaining within a user based on a time of a previous capping or decapping of the pen cap and a current time.

12. The pen cap of claim 11 , wherein the pen cap is adapted to determine an amount of insulin remaining in the insulin pen and to determine a dose amount for the time of a previous capping or decapping, wherein the pen cap displays an estimation of active insulin remaining within the user based a current time and the times and dose amounts associated with one or more a previous capping or decapping of the pen cap.

13. A pen cap for an insulin delivery device comprising:

at least one input device adapted to receive glucose data;

at least one circuit adapted to detect movement of the pen cap;

memory to store at least one user-specific dosage parameter or recommended dose; and

at least one processor adapted to determine content presented by a user interface, the processor using information relating to the use of the insulin delivery device,

wherein the pen cap is adapted to be responsive to the pen cap being motionless for at least a threshold period of time, and to display a recommended correction dose of insulin based on an insulin sensitivity factor and a target glucose value stored in memory.

Assignments (20)
SECURITY INTEREST Recorded Jan 10, 2025
From: BIGFOOT BIOMEDICAL, INC.
To: MADRYN HEALTH PARTNERS, LP
Reel/Frame 069870/0456 →
RELEASE OF SECURITY INTEREST Recorded Jan 10, 2025
From: MADRYN FUND ADMINISTRATION, LLC
To: BIGFOOT BIOMEDICAL, INC.
Reel/Frame 069870/0588 →
SECURITY INTEREST Recorded Jan 10, 2025
From: MADRYN HEALTH PARTNERS, LP
To: MADRYN FUND ADMINISTRATION, LLC
Reel/Frame 069870/0519 →
SECURITY INTEREST Recorded Sep 30, 2024
From: MADRYN HEALTH PARTNERS, LP
To: MADRYN FUND ADMINISTRATION, LLC
Reel/Frame 069074/0001 →
RELEASE OF SECURITY INTEREST Recorded Sep 30, 2024
From: MADRYN FUND ADMINISTRATION, LLC
To: BIGFOOT BIOMEDICAL, INC.
Reel/Frame 069071/0980 →
SECURITY INTEREST Recorded Sep 30, 2024
From: BIGFOOT BIOMEDICAL, INC.
To: MADRYN HEALTH PARTNERS, LP
Reel/Frame 069073/0912 →
SECURITY INTEREST Recorded Sep 24, 2024
From: MADRYN HEALTH PARTNERS, LP
To: MADRYN FUND ADMINISTRATION, LLC
Reel/Frame 069030/0104 →
SECURITY INTEREST Recorded Sep 24, 2024
From: BIGFOOT BIOMEDICAL, INC.
To: MADRYN HEALTH PARTNERS, LP
Reel/Frame 069030/0296 →
RELEASE OF SECURITY INTEREST Recorded Sep 24, 2024
From: MADRYN FUND ADMINISTRATION, LLC
To: BIGFOOT BIOMEDICAL, INC.
Reel/Frame 069030/0157 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 23, 2024
From: SJOLUND, JOHN; SRINATH, AMBIKA; BOCHENKO, ANDREW; CROTHALL, GEORGE; MAZLISH, BRYAN; DESBOROUGH, LANE; BLOCK, JENNIFER MARTIN; MATARESE, SARAH; MACKOWIAK, LINDA
To: BIGFOOT BIOMEDICAL, INC.
Reel/Frame 068660/0277 →
SECURITY INTEREST Recorded Sep 23, 2024
From: BIGFOOT BIOMEDICAL, INC.
To: MADRYN HEALTH PARTNERS, LP
Reel/Frame 069019/0142 →
SECURITY INTEREST Recorded Sep 23, 2024
From: MADRYN HEALTH PARTNERS, LP
To: MADRYN FUND ADMINISTRATION, LLC
Reel/Frame 069019/0188 →
RELEASE OF SECURITY INTEREST Recorded Sep 23, 2024
From: MADRYN FUND ADMINISTRATION, LLC
To: BIGFOOT BIOMEDICAL, INC.
Reel/Frame 069019/0346 →
RELEASE OF SECURITY INTEREST Recorded Sep 12, 2024
From: MADRYN FUND ADMINISTRATION, LLC
To: BIGFOOT BIOMEDICAL, INC.
Reel/Frame 068948/0377 →
SECURITY INTEREST Recorded Sep 12, 2024
From: MADRYN HEALTH PARTNERS, LP
To: MADRYN FUND ADMINISTRATION, LLC
Reel/Frame 068948/0324 →
SECURITY INTEREST Recorded Sep 12, 2024
From: BIGFOOT BIOMEDICAL, INC.
To: MADRYN HEALTH PARTNERS, LP
Reel/Frame 068948/0172 →
RELEASE OF SECURITY INTEREST Recorded Sep 26, 2023
From: MADRYN FUND ADMINISTRATION, LLC
To: BIGFOOT BIOMEDICAL, INC.
Reel/Frame 065029/0271 →
SECURITY INTEREST Recorded Feb 10, 2023
From: MADRYN HEALTH PARTNERS, LP
To: MADRYN FUND ADMINISTRATION, LLC
Reel/Frame 062702/0145 →
SECURITY INTEREST Recorded Mar 12, 2021
From: BIGFOOT BIOMEDICAL, INC.
To: MADRYN HEALTH PARTNERS, LP
Reel/Frame 055583/0044 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 26, 2020
From: SJOLUND, JOHN; SRINATH, AMBIKA; BOCHENKO, ANDREW; CROTHALL, GEORGE; MAZLISH, BRYAN; DESBOROUGH, LANE; BLOCK, JENNIFER MARTIN; MATARESE, SARAH; MACKOWIAK, LINDA
To: BIGFOOT BIOMEDICAL, INC.
Reel/Frame 052746/0378 →